NCT00413504View on ClinicalTrials.gov

Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism

NACompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

July 31, 2007

Conditions

Deep Vein ThrombosisPulmonary Embolism

Interventions

DRUG

Fondaparinux

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Brigham and Women's Hospital

OTHER